Leukocytes and systemic inflammatory response syndrome as prognostic factors in pulmonary embolism patients
Open Access
- 10 December 2013
- journal article
- research article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 13 (1) , 74
Abstract
Background: Hemodynamic status and cardiac function are important factors for predicting pulmonary embolism (PE) prognosis. Although inflammation is considered a risk factor for deep vein thrombosis, the prognostic significance of both systemic inflammatory response syndrome (SIRS) and leukocytosis has not been elucidated. This study evaluates PE prognostic factors, including SIRS and leukocytes. Methods: This retrospective cohort study included 667 PE patients. Risk evaluation included SIRS and leukocytosis. A prediction model was developed based on independent predictors of 30-day mortality. Results: Fifty-seven patients (8.5%) died within 30 days of PE. Multivariate analysis showed that SIRS satisfying the WBC criteria (odds ratio [OR], 2.8; 95% confidence interval [CI], 1.5–5.4), altered mental status (OR, 4.0; 95% CI, 1.8–8.7), shock (OR, 2.6; 95% CI, 1.0-7.1), and right-to-left ventricle diameter ratio (OR, 1.7; 95% CI, 1.0-2.8) were associated with 30-day mortality. SIRS criteria, including body temperature (OR, 4.6; 95% CI, 1.4–14.8), heart rate (OR, 2.0; 95% CI, 1.1–3.6), respiratory rate (OR, 2.5; 95% CI, 1.4–4.6), and white blood cells (WBC) count (OR, 1.9; 95% CI, 1.2–3.5) predicted short-term mortality following PE. The area under the receiver operating characteristic curve for the prognostic model performance was 0.76 (95% CI, 0.66–0.85); pulmonary embolism severity index (PESI) and PESI + WBC count were 0.72 (95% CI, 0.68–0.75) and 0.76 (95% CI, 0.72–0.79, P < 0.001 versus PESI), respectively. Conclusions: Leukocytosis and SIRS are important factors in determining short-term outcomes in PE patients.Keywords
This publication has 33 references indexed in Scilit:
- Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemiaAmerican Journal of Hematology, 2011
- Acute Pulmonary EmbolismNew England Journal of Medicine, 2010
- Estimated Incidence of Acute Pulmonary Embolism in a Korean HospitalClinical and Applied Thrombosis/Hemostasis, 2010
- Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-upJournal of Thrombosis and Haemostasis, 2009
- Virchow and his triad: a question of attributionBritish Journal of Haematology, 2008
- Recent Major Progress in Long-Term Cancer Patient Survival Disclosed by Modeled Period AnalysisJournal of Clinical Oncology, 2007
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Influenza infection and risk of acute pulmonary embolismThrombosis Journal, 2007
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- LABELLED LEUCOCYTES IN THROMBIThe Lancet, 1974